SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ...
Dr. Ryo Kubota, Acucela President and CEO, a Co-Author with Colleagues at Children’s Hospital and Harvard Medical of These Significant Findings BOTHELL, Wash.--(BUSINESS WIRE)-- Acucela, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback